Share this
HTG Completes its Initial Public Offering
May 20, 2015
KemPharm Completes its Initial Public Offering
April 28, 2015
Cooley Clients Featured in Daily Journal's "Top Deals of 2014"
March 25, 2015
New Relic Completes $132 Million Initial Public Offering
December 19, 2014
Cooley Advises AOL on Acquisition of Vidible
December 9, 2014
Atara Completes its Initial Public Offering
November 6, 2014
Cooley Advises Norwest Venture Partners on Formation of $1.2 Billion Fund
May 15, 2014
Cooley Advises Underwriters on Aerohive Networks IPO
April 4, 2014
Cooley Advises TriNet on its $276 Million Initial Public Offering
March 31, 2014
Cooley Advises Auspex on its Initial Public Offering
February 24, 2014
Cooley Advises Jazz Pharmaceuticals in Acquisition of ADX-N05
January 23, 2014
Cooley Advises Xencor on its Initial Public Offering
December 10, 2013
Cooley Advises Depomed in its $240 Million Diabetes Drug Sale to PDL BioPharma
October 22, 2013
FATCA Update: Effective Date Extended Six Months
Cooley Alert • July 16, 2013
Cooley Represents Backflip Studios in Acquisition by Hasbro
July 16, 2013
Cooley Advises Portola Pharmaceuticals on its $140 Million IPO
May 29, 2013
Cooley Advises Ambit on its Initial Public Offering
May 21, 2013
Cooley Advises Underwriters on Receptos, Inc. Initial Public Offering
May 20, 2013
Cooley Advises Hot Topic in its $600 Million Sale to Sycamore Partners
March 7, 2013
Government Finalizes FATCA Regulations
Cooley Alert • February 4, 2013
Cooley Advises JSM Acquisition in $800 Million Sale of San Diego Padres
August 29, 2012
Government Issues Comprehensive FATCA Regulations
Cooley Alert • February 23, 2012
House Passes Changes to Carried Interest Taxation; Proposed Effective Date Deferred to 2011
Cooley Alert • June 2, 2010
House Again Proposes Changes to Carried Interest Taxation
Cooley Alert • May 21, 2010
Compromise on Carried Interest Taxation May be Near
Cooley Alert • May 13, 2010